-
[文献書誌] Takeshita A, Shinjo K, Naito K, Fujisawa S, Shigeno K, Horii T, Maekawa M, Izumi M, Kitamura K, Ohnishi K, Naoe T, Ohno R.: "P-glycoprotein (P-gp) can be induced by arsenic trioxide (As_2O_3) therapy, but is not the main mechanism of As_2O_3-resistance in acute promyelocytic leukemia cells : analysis of P-gp and intracellular concentration of As_2O_3."Leukemia. 17. 648-650 (2003)
-
[文献書誌] Takeshita A.: "Recent advance in the treatment of acute myeloid leukemia."Int J Hematol. 78. 11-15 (2003)
-
[文献書誌] Sahara N.Takeshita A, Shigeno K, Fujisawa S, Takeshita K, Naito K, Ihara M, Ono T, Tamashima S, Nara K, Ohnishi K, Ohno R.: "Clinicopathological and prognostic characteristics of CD56-negative multiple myeloma."Leukemia and lymphoma. 45. 61-65 (2003)
-
[文献書誌] Sahara N.Takeshita A, Shigeno K, Fujisawa S, Takeshita K, Naito K, Ihara M, Ono T, Tamashima S, Nara K, Ohnishi K, Ohno R.: "Phenylarsine oxide (PAO) more intensely induces apoptosis in acute promyelocytic leukaemia (APL) and As_2O_3-resistant APL cell lines than As_2O_3 by activating the mitochondrial pathway."Leukemia and lymphoma. (in press).
-
[文献書誌] Takeshita A, Naito K, Shinjo K, Nakamura S, Sahara N, Matui H, Ohnishi K, Beppu H, Ohtsubo K, Hisatomi H, Horii T, Maekawa M, Inaba T, Ryuzo Ohno.: "del(6p23) and der(11p15) including NUP98 translocation in a case of secondary myeloproliferative disorder which eventually underwent clonal evolution and transformed to acute myeloid leukemia."Cancer Genet Cytogenet. (in press).
-
[文献書誌] Takeshita A, Uehara A, Shinjo K, Naito K, Sahara N, Yamazaki K, Katoh H, Kamikawa T, Ohnishi K, Maekawa M, Hayashi H, Ohno.: "Impairment of heart rate variability control during arsenic trioxide treatment for acute promyelocytic leukemia."Leukemia. (in press).
